Manufactured/Marketed/Promoted by: CYNO PHARMACEUTICALS
Gefitinib is a drug used in the treatment of certain types of cancer, particularly those with mutated and overactive EGFR.
Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor
(EGFR) in target cells.